Detalhe da pesquisa
1.
Development of inhalation powders containing lactic acid bacteria with antimicrobial activity against Pseudomonas aeruginosa.
Int J Antimicrob Agents
; 63(1): 107001, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37839715
2.
Metered dose inhalers in the transition to low GWP propellants: what we know and what is missing to make it happen.
Expert Opin Drug Deliv
; 20(8): 1131-1143, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37767756
3.
The impact of possible improper use on the performance in vitro of NEXThaler in comparison with Ellipta inhaler.
Eur J Pharm Sci
; 183: 106385, 2023 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36646153
4.
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro.
Pharmaceutics
; 15(3)2023 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36986883
5.
A dry powder formulation for peripheral lung delivery and absorption of an anti-SARS-CoV-2 ACE2 decoy polypeptide.
Eur J Pharm Sci
; 191: 106609, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37838239